QICHU BIOTECHNOLOGY LIMITED

Executive Summary

QICHU BIOTECHNOLOGY LIMITED is a dormant private limited company with a robust equity base and no overdue filings, indicating low immediate financial or regulatory risk. However, its lack of trading activity and concentrated ownership warrant further scrutiny of future business plans and governance structures. Overall, the company presents a low-risk profile predominantly due to its dormant status and clean compliance record.

QICHU BIOTECHNOLOGY LIMITED - Analysis Report

Company Number: 13500868

Analysis Date: 2025-07-19 11:53 UTC

1. Risk Rating: LOW
   QICHU BIOTECHNOLOGY LIMITED is a dormant private limited company with no trading activity reported since incorporation in 2021. The company maintains consistent net assets and shareholders’ funds of £500,000, reflecting paid-up share capital and no liabilities. There are no overdue filings or indications of financial distress.

2. Key Concerns:

• Dormant Status: The company has not conducted any business activity, which means no operational cash flow or revenue generation is present. This limits assessment of operational sustainability.
• Single Controlling Shareholder: One individual holds 75-100% ownership and voting rights, concentrating control which may pose governance risks if not managed transparently.
• Limited Public Financial Disclosure: Dormant accounts provide minimal financial details, restricting insight into potential hidden liabilities or contingent obligations.

3. Positive Indicators:

• Clean Compliance Record: All statutory filings, including accounts and confirmation statements, are up to date and not overdue, indicating good regulatory compliance.
• Strong Equity Base: The company’s net assets equal the fully paid share capital of £500,000, suggesting no accumulated losses or debts.
• Stable Company Status: The company is active and not subject to any insolvency procedures or director disqualifications.

4. Due Diligence Notes:

• Verify the reason for dormancy and any strategic plans for activation or capitalization.
• Confirm no undisclosed liabilities or off-balance sheet risks exist despite dormant status.
• Review governance arrangements given sole control by a single director/shareholder, including any related-party transactions or conflict of interest policies.
• Investigate the background and financial capacity of the sole director and shareholder for long-term stability.